Insomnia Guide » 2007 » April

“Non-pharmaceutical treatments and behavior modification can be extremely effective for sleep problems and should be considered as first-line therapy when appropriate.”

As more Americans turn to medications for a good night’s sleep, the introduction of a generic version of Ambien presents multi-million dollar savings for consumers and health plan sponsors, helping to offset … via PR-inside.com

From Insomnia News

By: BRADLEY J. FIKES - Staff Writer The pineal gland is an obscure, mysterious pea-sized organ tucked deep inside our skulls. via North County Times

From Insomnia News

Ranbaxy Laboratories Limited , announced today that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg. via PR-inside.com

From Insomnia News

A Harvard study released Monday supports earlier findings by a panel of experts that having an abortion doesn’t increase a woman’s risk of getting breast cancer. via Lexington Herald-Leader

From Insomnia News

A significant number of patients with major depression also suffer from chronic insomnia that hampers recovery, a sleep expert said here. via Psychiatric Times

From Insomnia News

The U.S. Food and Drug Administration has approved the first generic versions of Ambien for the treatment of insomnia. via UPI

From Insomnia News

Slick and Springy: Brown Research Reveals Protein’s Role in Joints [Brown University] FDA Approves First Generic Versions of Ambien for the Treatment of Insomnia [FDA] First Demonstration of Muscle Restoration … via Medgadget

From Insomnia News

The first generic versions of the insomnia drug Ambien won federal approval Monday.

The Food and Drug Administration said it approved versions of the immediate-release tablets made by 13 drug companies for the short-term treatment of insomnia. A patent held by Paris-based Sanofi-Aventis on the drug, also called zolpidem tartrate, expired Saturday.

The approvals of generic versions of the drug come a month after the FDA asked makers of it and similar sleep aids to beef up warnings about their potential risks. The risks of the sedative-hypnotic drugs include severe allergic reactions and complex sleep-related behaviors, like sleep-driving. Read more

From Insomnia News

Memorable ads lead to memorable results, right? Not always. After unveiling a well-received campaign featuring Abe Lincoln and a bucktoothed rodent, Japanese drugmaker Takeda has seen drowsy sales of its new … via CNN

From Insomnia News

Philadelphia Business Journal - 10:57 AM EDT Thursday, April 19, 2007 H. Lundbeck A/S had decided to close its office in King of Prussia, Pa., the site where the Danish pharmaceutical company had intended to … via Bizjournals.com

From Insomnia News